source
- DC judge dismisses Merck's challenge to Medicare drug price negotiationsA Washington D.C. federal judge rejected Merck's lawsuit contesting Medicare drug price negotiations under the Inflation Reduction Act. Judge Colleen Kollar-Kotelly of the U.S. District Court for t…
- Regenxbio faces second FDA clinical hold, delaying Hunter syndrome gene therapy filingRegenxbio announced that its gene therapy for Hunter syndrome has received a second clinical hold from the FDA this year. The company said it no longer expects to submit an NDA or seek approval in…